Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles from the last 7 days matching "Parkinson Disease"

AdvocacyRSSYesterday

Balancing safety and individual autonomy in Parkinson’s disease

This article discusses an important challenge that families with Parkinson's disease face: deciding when a loved one should stop driving or reduce their independence due to safety concerns. The piece uses the example of noticing a parent swerving while driving to illustrate how difficult these conversations can be. It explores the tension between keeping someone safe and respecting their right to make their own choices.

WHY IT MATTERSParkinson's disease patients and caregivers need guidance on recognizing when symptoms like freezing episodes or motor control problems make activities like driving unsafe, so they can have informed conversations about maintaining safety without unnecessarily restricting independence.
💬 Ask your doctorParkinson's disease
PolicyRSS3 days ago

First US state passes ban on paraquat, herbicide tied to higher Parkinson’s risk

Vermont has become the first state in the US to ban paraquat, a weed-killing chemical that scientists have linked to a higher risk of developing Parkinson's disease. Similar bans are being considered in about a dozen other states, including New York, Pennsylvania, and Minnesota. This action is based on research showing that exposure to paraquat may increase the chances of getting Parkinson's disease.

WHY IT MATTERSIf you have Parkinson's disease or a family history of it, this ban reduces your potential exposure to a chemical that research suggests may trigger or worsen the condition.
Good to knowParkinson's disease

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases